GPLD1 and non-small cell lung carcinoma: Targeting GPLD1 has been found to inhibit the proliferation of non-small cell lung cancer cells mediated by p38 MAP kinase (43) Knockdown or silencing of FABP5 has been shown to reduce the proliferation and invasiveness of PC cells in vitro and reduce tumor growth and metastasis in vivo (44).